Cancer Care Ontario | Cancer Care Ontario

361 Results

Guidelines and Advice

Systemic Therapy for Advanced or Recurrent Endometrial Cancer and Advanced or Recurrent Uterine Papillary Serous Carcinoma

Status: In-Review
ID: 4-8
Version: 4

Jul 2019

Guidelines and Advice

Systemic Therapy for Recurrent, Metastatic, or Persistent Cervical Cancer

Status: Current
ID: 4-20
Version: 2

Nov 2014

Guidelines and Advice

Hepatic, Pancreatic and Biliary Tract Surgical Oncology Standards

Status: In-Review
ID: 17-2 Version 2
Version: 2

Dec 2015

Guidelines and Advice

Optimal Therapy for Patients Diagnosed with Multiple Myeloma and the Role of High-Dose Chemotherapy and Stem Cell Support

Status: Education and Information
ID: 6-6 Version 2
Version: 2

Jan 2012

Guidelines and Advice

Adjuvant Care for Stage I Ovarian Cancer

Status: Current
ID: 4-13
Version: 3

Mar 2022

Guidelines and Advice

Zoledronic Acid as Adjuvant Therapy in Combination with Adjuvant Endocrine Therapy for Premenopausal Women with Early-Stage Hormone Receptor Positive Breast Cancer

Status: Archived
ID: CED 16

Jan 2010

Guidelines and Advice

The Prophylactic Use of Filgrastim in Patients with Breast Cancer

Status: Archived
ID: CED 14-2

Oct 2009

Guidelines and Advice

The Prophylactic Use of Filgrastim in Patients with Hematological Malignancies

Status: Archived
ID: CED 14-1

Sep 2009

Guidelines and Advice

The Role of Aromatase Inhibitors in Adjuvant Therapy for Postmenopausal Women with Hormone Receptor-positive Breast Cancer

Status: Archived
ID: 1-18

May 2012

Guidelines and Advice

The Role of Taxanes in Neoadjuvant Chemotherapy for Women with Non-metastatic Breast Cancer

Status: Archived
ID: 1-20
Version: 2

Oct 2011

Guidelines and Advice

The Role of Trastuzumab in Adjuvant and Neoadjuvant Therapy in Women with HER2/neu-overexpressing Breast Cancer

Status: Education and Information
ID: 1-24 Version 2
Version: 2

May 2006

Guidelines and Advice

The Use of Bevacizumab in Metastatic Breast Cancer

Status: Archived
ID: CED 12

Apr 2009

Systemic Therapy for Advanced or Recurrent Endometrial Cancer and Advanced or Recurrent Uterine Papillary Serous Carcinoma

Systemic Therapy for Recurrent, Metastatic, or Persistent Cervical Cancer

Hepatic, Pancreatic and Biliary Tract Surgical Oncology Standards

Optimal Therapy for Patients Diagnosed with Multiple Myeloma and the Role of High-Dose Chemotherapy and Stem Cell Support

Adjuvant Care for Stage I Ovarian Cancer

Zoledronic Acid as Adjuvant Therapy in Combination with Adjuvant Endocrine Therapy for Premenopausal Women with Early-Stage Hormone Receptor Positive Breast Cancer

The Prophylactic Use of Filgrastim in Patients with Breast Cancer

The Prophylactic Use of Filgrastim in Patients with Hematological Malignancies

The Role of Aromatase Inhibitors in Adjuvant Therapy for Postmenopausal Women with Hormone Receptor-positive Breast Cancer

The Role of Taxanes in Neoadjuvant Chemotherapy for Women with Non-metastatic Breast Cancer

The Role of Trastuzumab in Adjuvant and Neoadjuvant Therapy in Women with HER2/neu-overexpressing Breast Cancer

The Use of Bevacizumab in Metastatic Breast Cancer

Pages